Dr. Shuhao Wen, co-founder, chairman of the board, and executive director of XtalPi Inc.

In 2015, during his postdoc fellowship at MIT, Wen Shuhao co-founded XtalPi in Boston with two other quantum physicists from MIT, and served as Chairman of the Board. The company combines quantum physics, AI, cloud computing, and large-scale robotics experiments to provide R&D solutions, services, and products for pharmaceuticals, biotechnology, renewable energy, and advanced materials industries globally.

In June 2024, XtalPi successfully went public on the Hong Kong Stock Exchange (HKEX) and made history as the first IPO under HKEX’s new Chapter 18C listing rules for Specialized Technology Companies. XtalPi was the first “AI drug discovery” IPO and the first “AI+robotics” IPO in Greater China. Within three months of its listing, the company achieved a market capitalization of HKD 50 billion.

Wen is also an angel investor. Through incubation, investments, and collaboration with XtalPi, Wen helped launch over a dozen startups in life sciences and new materials, including METiS Pharmaceuticals, Signet Therapeutics, Leman Biotech, and META Pharmaceuticals Inc.